NCT06145633 2026-01-28
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Fred Hutchinson Cancer Center
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04357873 2025-02-19
PEVOsq
UNICANCER
Phase 2 Completed
NCT00278395 2017-11-14
Vorinostat in Treating Patients With Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00589472 2017-10-06
TARGET
National Cancer Institute (NCI)
Phase 2 Completed
NCT00363883 2015-02-13
Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00330161 2014-05-26
Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed